# OnCo record jiaray-group (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/jiaray-group/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "jiaray-group" ;
  schema:name "JiaRay Group"@en ;
  schema:alternateName "JiaRay Therapeutics, Inc."@en, "JiaRay Biopharmaceuticals, Ltd."@en, "JiaRay Pharmaceuticals, Inc."@en ;
  schema:description "JiaRay Group is developing JR8603, a chemotherapy drug attached to a short peptide that is meant to be cut free only inside tumours by an enzyme called legumain. It is in a first trial in people with advanced solid tumours, including stomach and bowel cancer."@en ;
  schema:url <https://onco.cc/companies/jiaray-group/>, <https://jiaraygroup.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://jiaraygroup.com/>, <https://jiaraygroup.com/jiaray-group/>, <https://clinicaltrials.gov/study/NCT06783569> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/gastric/>, <https://onco.cc/cancers/colorectal/> ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/>, <https://onco.cc/fronts/chemotherapy/> ;
  onco:technologies <https://onco.cc/technologies/peptide-drug-conjugate/> .